posted on 2025-05-20, 10:45authored byDipayan Chakraborty, Wenchuan Ma, Peter G. Vekilov, Jeffrey D. Rimer
The underlying mechanisms of cholesterol crystallization
are generally
not well understood, despite its critical role in physiological and
pathological processes of the human body. One challenge associated
with studying cholesterol crystallization in vitro is the identification of a biomimetic solvent that allows for in situ characterization. In this study, we explore various
alcohol–water solvents and show that the selection of alcohol
is critical to achieving physiologically relevant cholesterol monohydrate
crystals, whereas other alcohols may give rise to cholesterol solvates.
In particular, we focus on ethanol–water solvents and show
that these systems produce a combination of monohydrate and hemiethanolate
crystals, depending on the water content. A combination of several
scattering techniques reveals the formation of mesoscopic solute-rich
clusters over a broad range of cholesterol concentrations spanning
from undersaturated to supersaturated solutions. The presence of clusters
is highly suggestive of a nonclassical (two-step) nucleation pathway.
We explore the impact of three growth conditions, water content, cholesterol
concentration, and temperature, on the size and population of clusters.
We observe that cluster size varies only with temperature, whereas
the number of clusters increases with increasing water content and
cholesterol concentration. In situ atomic force microscopy measurements
reveal a classical mechanism of cholesterol hemiethanolate crystal
growth based on monomer addition via a surface diffusion pathway without
the involvement of mesoscopic solute-rich clusters. The incorporation
of the solute by surface diffusion invokes strong competition for
supply between adjacent steps on crystal surfaces, which leads to
a unique self-inhibition pathway that has the potential to induce
surface growth cessation. Collectively, these findings highlight the
importance of solvent selection in studies of cholesterol crystallization
and the ability of these systems to have disparate nonclassical and
classical pathways of nucleation and growth, respectively.